BioSpace News Archive

Business

Billy Dunn’s Prothena Board Position Reignites Ethical Debate

Ex-FDA Neuroscience Director Billy Dunn was appointed to Prothena’s board of directors last week. Industry representatives and regulatory experts weigh in on the potential ethical implications.

May 23, 2023
·
5 min read
·
Heather McKenzie
FDA

FDA Approves First Nasal Nalmefene Spray for Opioid Overdose

Indivior’s Opvee is an emergency nasal spray medication to reverse opioid overdose approved for patients aged 12 years and above with signs of respiratory or central nervous system depression.

May 23, 2023
·
2 min read
·
Tristan Manalac
10 Pharma Tech Jobs Available Now

Check out BioSpace’s guide to pharma tech jobs, complete with job descriptions and average salaries.

May 23, 2023
·
3 min read
·
Rosemary Scott
Moving From the Bench to Management: How to Become an Effective Leader

Here are some of the skills and tools life science researchers and scientists can use to become successful managers.

May 23, 2023
·
4 min read
·
Eden Whitlock
FDA

Blueprint Adds Indolent Systemic Mastocytosis to Ayvakit’s Label

With the FDA’s approval on Monday, Ayvakit is the first and only treatment for adults with indolent systemic mastocytosis, a rare hematologic disorder, according to Blueprint Medicines.

May 23, 2023
·
2 min read
·
Tristan Manalac
Drug Development

Roche Terminates Second Phase II Schizophrenia Trial

The Swiss pharma has canceled a second mid-stage trial for its investigational schizophrenia drug ralmitaront, as the competition shows promise in the space.

May 23, 2023
·
2 min read
·
Kate Goodwin
Business

ReNAgade Launches with $300M to More Easily Deliver RNA Medicines

The Massachusetts-based startup’s goal is to develop RNA medicines that can treat diseases anywhere in the body using an “all-in-one” platform.

May 23, 2023
·
2 min read
·
Tristan Manalac
Pharm Country

Lupus Research Alliance and its Clinical Research Affiliate Lupus Therapeutics Launch the Lupus Landmark Study to Accelerate Personalized Treatments in Lupus

The Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics today announced the launch of the Lupus Landmark Study, a groundbreaking observational research study to accelerate the development of personalized treatments for people living with lupus.

May 23, 2023
·
5 min read
Pharm Country

Y-mAbs’ DANYELZA® (naxitamab-gqgk) for the Treatment of High-Risk Neuroblastoma approved in Brazil

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that the Brazilian Health Regulatory Agency, Agência Nacional de Vigilância Sanitária (“Anvisa”) has granted marketing authorization for DANYELZA (naxitamab-gqgk) 40mg/10mL injection.

May 23, 2023
·
5 min read
Pharm Country

Centinel Spine® to Host Major Worldwide Live Surgery Broadcast in Two-Day Meeting on Lumbar Disc Arthroplasty featuring prodisc® L Total Disc Replacement

Centinel Spine®, LLC will host a major global two-day virtual meeting on lumbar disc arthroplasty featuring the prodisc L TDR as part of the Company’s med+ Medical Education program.

May 23, 2023
·
4 min read